why choose us

First received: November 22, 2022

Clinical Trial: Kesimpta (Ofatumumab) Pregnancy Registry

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Sclerosis

Study Type: OBSERVATIONAL


Official Title: Post-Authorization Safety Study for Assessment of Pregnancy and Infant Outcomes in Patients Treated With Kesimpta (Ofatumumab) Using OTIS Observational Pregnancy Surveillance Program and DMSKW Registr

Brief Summary: The Kesimpta Pregnancy Registry is an observational, exposure cohort designed study to examine pregnancy and infant outcomes in women and infants who are exposed to Kesimpta (ofatumumab) during pregnancy to treat MS.

Read more